-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$32.75-18.02% Downside
IVERIC bio, Inc. Frequently Asked Questions
-
What analysts cover IVERIC bio, Inc.?
IVERIC bio, Inc. has been rated by research analysts at Stifel Nicolaus, Guggenheim, Robert W. Baird, Jefferies in the past 90 days.